Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: What has Changed in The Guidelines?

BACKGROUND: The new European Society of Cardiology guidelines for hypertrophic cardiomyopathy (HCM) define the estimation of sudden cardiac death (SCD) risk as an integral part of clinical management. An implantable cardioverter defibrillator (ICD) is recommended (class IIa) when the risk is ≥ 6%. O...

Descripción completa

Detalles Bibliográficos
Autores principales: Reis, Liliana, Teixeira, Rogerio, Fernandes, Andreia, Almeida, Inês, Madeira, Marta, Silva, Joana, Botelho, Ana, Pais, João, Nascimento, José, Gonçalves, Lino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cardiologia - SBC 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023627/
https://www.ncbi.nlm.nih.gov/pubmed/30226910
http://dx.doi.org/10.5935/abc.20180099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023627/
https://www.ncbi.nlm.nih.gov/pubmed/30226910
http://dx.doi.org/10.5935/abc.20180099

Ejemplares similares